Report Code: A03271 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Muscarinic acetylcholine receptors are a subtype of acetylcholine receptors. In the cell membranes of certain neurons and other cells, these cells form G protein-receptor complexes. These receptors are activated in the presence of acetylcholine that are released from postganglionic fibers in the parasympathetic nervous system. Acetylcholine acts as neurotransmitters in the peripheral nervous system and central nervous system. Acetylcholine activates muscles in the peripheral nervous system and causes excitatory actions in the central nervous system.
Muscarinic acetylcholine receptors play a vital role in the treatment of diseases such as chronic obstructive pulmonary disease, Alzheimer, and psychiatric disorders. The rise in the incidence of these diseases will increase the demand for muscarinic acetylcholine receptors. Moreover, the increased R&D activity for the therapeutic contribution of these receptors will help boost the market growth. However, stringent government regulations can restrain the growth.
The global muscarinic acetylcholine receptor market is segmented based on type, application, and geography. Based on type, the market is segmented into M1, M4, M5, and others. Based on application, the market is categorized into chronic obstructive pulmonary disease, attention deficit hyperactivity disorder, Alzheimers disease, memory impairment, and psychiatric disorders. Based on geography, the market has been examined across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as Heptares Therapeutics Ltd., Sumitomo Dainippon Pharma Co. Ltd., Anavex Life Sciences Corp., NeuroHealing Pharmaceuticals Inc., AstraZeneca Plc., and Karuna Pharmaceuticals Inc. have also been provided in this report.
Key Benefits
Muscarinic Acetylcholine Receptor Market Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Application |
|
By Region |
|
Key Market Players | Anavex Life Sciences Corp., AstraZeneca Plc., Heptares Therapeutics Ltd., Sumitomo Dainippon Pharma Co. Ltd., Karuna Pharmaceuticals Inc., NeuroHealing Pharmaceuticals Inc. |
Loading Table Of Content...
Start reading.
This Report and over 71,321+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers